Advancements in technology, and in particular, developments in artificial intelligence (AI) are revolutionising the way that we live our lives. Up to now, we have used it to help us find the quickest route home or to search the Internet, but we now need to look much further. Read More
Alnylam Pharmaceuticals has new data from the open-label extension (OLE) period of the ENVISION Phase 3 study This shows the long-term therapeutic benefit of givosiran in patients with acute hepatic porphyria (AHP)—an orphan disease that can be life threatening. The results were presented by study investigator… Read More
Continuing to challenge the current HIV treatment paradigm, data presented will investigate new and innovative treatment options for people living with HIV. ViiV Healthcare will be presenting over 20 abstracts during next week at the 23rd International AIDS Conference (AIDS 2020: Virtual), being held 6-10 July. Because of… Read More
The UK based AI start-up is offering all researchers free use of Galactic, its cloud-based web tool, to support biomedical research while lab access is restricted around the world. According to Biorelate, the cognitive computing platform behind Galactic can speed up the research process by collecting and curating… Read More
Start Codon, life science and healthcare business accelerator, has showcased its first cohort of start-ups. The company aims to minimise risk and translate early stage research into successful start-ups, ready for funding and partnership. Start Codon has been working closely with four life science and healthcare companies that… Read More
Start-up iLoF (Intelligent Lab on Fiber), uses artificial intelligence (AI) and biophotonics to detect neurogenerative biomarkers and optimise the clinical trial selection process for diseases such as Alzheimer’s. iLoF also won the EIT Health Wild Card competition in 2019 and has secured $1 million in investment from Microsoft’s… Read More
The Personalized Medicine Coalition The Personalized Medicine Coalition (PMC), representing a broad spectrum of academic, industrial, patient, provider, and payer communities, seeks to advance the understanding and adoption of personalized medicine concepts and products for the benefit of patients. As part of its… Read More
Collaborative Research Leads To New Understanding Of Biomarkers By Dr Max Ryadnov and Professor Jason Crain A new collaborative research paper sheds light on the way antibodies distinguish between different but closely related ‘biomarkers’ – in this case protein fragments which reveal information about the condition of the… Read More
Measuring Silicone Oil Interaction With Protein Using Hound Sponsored by Unchained Labs Many biologic drugs are lipophilic, meaning they are prone to strong negative interactions with the silicone oil used to lubricate prefilled syringes and vials. Protein – silicone oil interactions can cause protein aggregation and… Read More
Guidelines & Recommendations For Analyzing and Interpreting GPCR Second Messenger Data Sponsored by CisBio The question of choosing which methods to use for analyte quantification (signal vs concentration determination, parameters, and format) continues to generate heated debates and divergent understanding. Today, there is still… Read More
Unleashing High-Throughput Reaction Screening The Unchained way Sponsored by Unchained Labs A successful high-throughput approach to reaction screening requires rational and systematic exploration of a broad set of variables to achieve optimization expeditiously. There are many types of potential variables that can be screened. Even with… Read More
Stem Cell Differentiation By Dr Lilian Hook Stem cells are extraordinary cells, capable of both self-renewal and differentiation to mature somatic cells in vivo and in vitro (1,2). They have many features and advantages which could revolutionise drug development and healthcare applications. Read More
Phenotypic Drug Discovery With High Content Screening Sponsored by PerkinElmer Early drug discovery used to be conducted mainly in a target-agnostic fashion, focusing on qualitative readouts from a living system – cells, tissue, or organisms – and asking the question, did this entity affect the phenotype?… Read More
Meet Big Tuna: Automated, Versatile Buffer Exchange Sponsored by Unchained Labs Conventional exchange methods are labor-intensive, prone to inconsistency, and difficult to manage in larger numbers. Introduction The critical process of screening formulation buffers to optimize stability is labor intensive… Read More
Meet Stunner: The One-Shot Protein Concentration and Sizing Combo Sponsored by Unchained Labs Stunner pulls double-duty so you don’t have to. It’s the one and only system that combines high-speed UV/Vis spectral analysis and Dynamic Light Scattering (DLS) for quantifying concentration and nailing down protein stability. Read More
Targeting Energy Metabolism for Cancer Therapeutic Discovery using Agilent Seahorse XF Technology Sponsored by Agilent This white paper discusses targeting energy metabolism for cancer therapeutic discovery using Agilent Seahorse XF technology. Abstract Altered energy metabolism is now recognized as a driver… Read More